Metabolism of ??-linolenic acid in humans, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.75, issue.3, pp.161-168, 2006. ,
DOI : 10.1016/j.plefa.2006.05.013
Mechanisms of action of docosahexaenoic acid in the nervous system, Lipids, vol.68, issue.9, pp.945-959, 2001. ,
DOI : 10.1007/s11745-001-0805-6
Fish Oil Fatty Acids as Cardiovascular Drugs, Current Vascular Pharmacology, vol.6, issue.1, pp.11-12, 2008. ,
DOI : 10.2174/157016108783331286
Computer-based modeling of the conformation and packing properties of docosahexaenoic acid, J Lipid Res, vol.27, pp.658-680, 1986. ,
Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function, Biochemical and Biophysical Research Communications, vol.117, issue.2, pp.549-555, 1983. ,
DOI : 10.1016/0006-291X(83)91235-4
Docosahexaenoic acid (22:6, n-3) is metabolized to lipoxygenase reaction products in the retina, Biochemical and Biophysical Research Communications, vol.125, issue.2, pp.741-747, 1984. ,
DOI : 10.1016/0006-291X(84)90601-6
Different metabolic behavior of long-chain n???3 polyunsaturated fatty acids in human platelets, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.961, issue.2, pp.262-269, 1988. ,
DOI : 10.1016/0005-2760(88)90121-X
Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle, Biochemical Pharmacology, vol.37, issue.7, pp.1275-1280, 1988. ,
DOI : 10.1016/0006-2952(88)90782-4
Metabolic fate of an oral tracer dose of [13C]docosahexaenoic acid triglycerides in the rat, Am J Physiol, vol.270, pp.846-854, 1996. ,
Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells, J Lipid Res, vol.38, pp.1571-1582, 1997. ,
Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [(13)C]DHA in phosphatidylcholine, J Lipid Res, vol.40, pp.1867-1874, 1999. ,
n-3 fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supplementation, Am J Clin Nutr, vol.64, pp.297-304, 1996. ,
Arterial Aging: Is It an Immutable Cardiovascular Risk Factor?, Hypertension, vol.46, issue.3, pp.454-462, 2005. ,
DOI : 10.1161/01.HYP.0000177474.06749.98
Platelets and aging I.???Aggregation, arachidonate metabolism and antioxidant status, Thrombosis Research, vol.49, issue.3, pp.49-331, 1988. ,
DOI : 10.1016/0049-3848(88)90313-1
Age-related changes in arachidonic acid peroxidation and glutathione-peroxidase activity in human platelets, Prostaglandins, vol.43, issue.1, pp.75-85, 1992. ,
DOI : 10.1016/0090-6980(92)90067-4
Low levels of hydrogen peroxide enhance platelet aggregation by cyclooxygenase activation, Eicosanoids, vol.4, pp.107-113, 1991. ,
Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation, Biochemical Journal, vol.325, issue.2, pp.495-500, 1997. ,
DOI : 10.1042/bj3250495
The influence of low intake of n-3 fatty acids on platelets in elderly people, Atherosclerosis, vol.147, issue.1, pp.187-192, 1999. ,
DOI : 10.1016/S0021-9150(99)00171-9
Functions and tocopherol content of blood platelets from elderly people after low intake of purified eicosapentaenoic acid, Thrombosis Research, vol.57, issue.1, pp.57-58, 1990. ,
DOI : 10.1016/0049-3848(90)90190-N
Increasing intakes of the long-chain ??-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men, The FASEB Journal, vol.23, issue.9, pp.2909-2916, 2009. ,
DOI : 10.1096/fj.09-133421
URL : https://hal.archives-ouvertes.fr/inserm-00387440
Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy men, Atherosclerosis, vol.208, issue.2, pp.467-472, 2010. ,
DOI : 10.1016/j.atherosclerosis.2009.07.049
URL : https://hal.archives-ouvertes.fr/inserm-00416728
Effects of increasing docosahexaenoic acid intake in human healthy volunteers on lymphocyte activation and monocyte apoptosis, British Journal of Nutrition, vol.130, issue.06, pp.852-858, 2009. ,
DOI : 10.1016/j.clnu.2006.03.004
URL : https://hal.archives-ouvertes.fr/inserm-00322838
Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid, Biochemical and Biophysical Research Communications, vol.117, issue.1, pp.282-288, 1983. ,
DOI : 10.1016/0006-291X(83)91572-3
Effect of dietary supplementation with increasing doses of docosahexaenoic acid on neutrophil lipid composition and leukotriene production in human healthy volunteers, British Journal of Nutrition, vol.1210, issue.04, pp.829-833, 2008. ,
DOI : 10.1079/BJN2003901
URL : https://hal.archives-ouvertes.fr/inserm-00267466
Pro- and antioxidant activities of docosahexaenoic acid on human blood platelets, Journal of Thrombosis and Haemostasis, vol.279, issue.3, pp.566-572, 2003. ,
DOI : 10.1046/j.1538-7836.2003.00076.x
Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.75, issue.3, pp.179-182, 2006. ,
DOI : 10.1016/j.plefa.2006.05.006
Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions, Chemistry and Physics of Lipids, vol.157, issue.1, pp.1-11, 2009. ,
DOI : 10.1016/j.chemphyslip.2008.09.004
Synthesis of hydroxy fatty acids from 4, 7, 10, 13, 16, 19-[1-14C] docosahexaenoic acid by human platelets, J Biol Chem, vol.258, pp.9339-9343, 1983. ,
Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers, Lipids, vol.33, issue.69, pp.1125-1132, 2004. ,
DOI : 10.1007/s11745-004-1339-7
Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.79, issue.3-5, pp.157-163, 2008. ,
DOI : 10.1016/j.plefa.2008.09.012
Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1, The Journal of Lipid Research, vol.51, issue.8, pp.2018-2031, 2010. ,
DOI : 10.1194/jlr.R001131
Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation, FEBS Letters, vol.94, issue.21, pp.583-3478, 2009. ,
DOI : 10.1016/j.febslet.2009.10.004
URL : https://hal.archives-ouvertes.fr/inserm-00429322
Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation, The FASEB Journal, vol.25, issue.1, pp.25-382, 2011. ,
DOI : 10.1096/fj.10-161836
URL : https://hal.archives-ouvertes.fr/inserm-00517396